Edward H. Lin

3.0k total citations
51 papers, 1.6k citations indexed

About

Edward H. Lin is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Edward H. Lin has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 13 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Edward H. Lin's work include Colorectal Cancer Treatments and Studies (14 papers), Colorectal Cancer Surgical Treatments (10 papers) and Colorectal and Anal Carcinomas (10 papers). Edward H. Lin is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Colorectal Cancer Surgical Treatments (10 papers) and Colorectal and Anal Carcinomas (10 papers). Edward H. Lin collaborates with scholars based in United States, China and Switzerland. Edward H. Lin's co-authors include Christopher H. Crane, Nora A. Janjan, Marc E. Delclos, Barry W. Feig, John M. Skibber, Miguel A. Rodrı́guez-Bigas, Jeffrey S. Morris, Gregory D. Ayers, Robert A. Wolff and Keping Xie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Edward H. Lin

51 papers receiving 1.6k citations

Peers

Countries citing papers authored by Edward H. Lin

Since Specialization

Citations

This map shows the geographic impact of Edward H. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward H. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward H. Lin more than expected).

Fields of papers citing papers by Edward H. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward H. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward H. Lin. The network helps show where Edward H. Lin may publish in the future.

Co-authorship network of co-authors of Edward H. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Edward H. Lin. A scholar is included among the top collaborators of Edward H. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward H. Lin. Edward H. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of AhR signaling 2023 ·PubMed ·(unknown), Edward H. Lin, (unknown), (unknown), Zafar K. Khan, Joris Beld, (unknown)	3
2	Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers 2021 ·Cancers ·(unknown), (unknown), Edward H. Lin, (unknown), (unknown), Pooja Jain	78
3	Peripheral Blood Mononuclear CD133 mRNA Levels Correlates with Response to Treatment in Patients with Gastrointestinal Stromal Tumors 2013 ·PLoS ONE ·Yanhong Deng, Manal M. Hassan, (unknown), Edward H. Lin	2
4	Multidisciplinary Management of Locally Advanced Rectal Cancer: Neoadjuvant Approaches 2013 ·Journal of the National Comprehensive Cancer Network ·Swaminathan Murugappan, William Proctor Harris, Christopher G. Willett, Edward H. Lin	4
5	Cost-effectiveness of biomarker-directed bevacizumab for first-line therapy of persons with metastatic colorectal cancer. 2012 ·Journal of Clinical Oncology ·Kristin Berry, Mark Bensink, (unknown), Veena Shankaran, Edward H. Lin, Uri Ladabaum, (unknown), (unknown), Scott D. Ramsey	1
6	CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality? 2011 ·Current Colorectal Cancer Reports ·(unknown), Yingjie Lin, Yan Xie, Qiang Tian, Linheng Li, Edward H. Lin	36
7	Temporal Patterns of Fatigue Predict Pathologic Response in Patients Treated With Preoperative Chemoradiation Therapy for Rectal Cancer 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Hee Chul Park, Nora A. Janjan, Tito R. Mendoza, Edward H. Lin, Saroj Vadhan‐Raj, Mandeep Hundal, Yiqun Zhang, Marc E. Delclos, Christopher H. Crane, Prajnan Das, Xin Shelley Wang, Charles S. Cleeland, Sunil Krishnan	23
8	High Epidermal Growth Factor Receptor Expression in Metastatic Colorectal Cancer Lymph Nodes May Be More Prognostic of Poor Survival Than in Primary Tumor 2009 ·American Journal of Clinical Oncology ·Yanhong Deng, Brenda F. Kurland, Jianping Wang, (unknown), Wen Li, Sujata Rao, Ping Lan, Tong-Yu Lin, Edward H. Lin	16
9	Targeting Stem Cells-Clinical Implications for Cancer Therapy 2009 ·Current Stem Cell Research & Therapy ·Lan N. Tu, Greg Foltz, Edward H. Lin, Leroy Hood, Qiang Tian	44
10	Capecitabine Plus 3-Weekly Irinotecan (XELIRI Regimen) as First-Line Chemotherapy for Metastatic Colorectal Cancer 2007 ·American Journal of Clinical Oncology ·Yehuda Z. Patt, (unknown), James E. Liebmann, (unknown), Sabine Eckhardt, Milind Javle, Glen R. Justice, (unknown), (unknown), Alice Bexon, Edward H. Lin	36
11	Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer 2006 ·Cancer ·Paulo M. Hoff, Robert A. Wolff, Henry Xiong, Dennie V. Jones, Edward H. Lin, Cathy Eng, (unknown), (unknown), James L. Abbruzzese	8
12	Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Prajnan Das, Edward H. Lin, S. Bhatia, John M. Skibber, Miguel A. Rodrı́guez-Bigas, Barry W. Feig, George J. Chang, Paulo M. Hoff, Cathy Eng, Robert A. Wolff, Marc E. Delclos, Sunil Krishnan, Nora A. Janjan, Christopher H. Crane	61
13	Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Sunil Krishnan, Nora A. Janjan, John M. Skibber, Miguel A. Rodrı́guez-Bigas, Robert A. Wolff, Prajnan Das, Marc E. Delclos, George J. Chang, Paulo M. Hoff, Cathy Eng, Thomas D. Brown, Christopher H. Crane, Barry W. Feig, Jeffrey S. Morris, Saroj Vadhan‐Raj, Stanley R. Hamilton, Edward H. Lin	94
14	Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Mark Bonnen, Christopher H. Crane, Jean‐Nicolas Vauthey, John M. Skibber, Marc E. Delclos, Miguel A. Rodrı́guez-Bigas, Paulo M. Hoff, Edward H. Lin, Cathy Eng, Adrian Wong, Nora A. Janjan, Barry W. Feig	140
15	Assessment of cyclooxygense-2 expression with 99mTc-labeled celebrex 2004 ·Anti-Cancer Drugs ·David J. Yang, Jerry Bryant, (unknown), Richard Mendez, Chang‐Sok Oh, Dongfang Yu, Megumi Ito, Ali Azhdarinia, Sahar Kohanim, (unknown), Edward H. Lin, Donald A. Podoloff	25
16	NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells 2003 ·International Journal of Cancer ·Henry Q. Xiong, James L. Abbruzzese, Edward H. Lin, Liwei Wang, Leizhen Zheng, Keping Xie	95
17	The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer 2003 ·International Journal of Radiation OncologyBiologyPhysics ·Christopher H. Crane, John M. Skibber, Elisa H. Birnbaum, Barry W. Feig, (unknown), Marc E. Delclos, Edward H. Lin, James W. Fleshman, Howard D. Thames, Ira J. Kodner, Mary Ann Lockett, Joel Picus, (unknown), (unknown), Nora A. Janjan, Thomas E. Read, Robert J. Myerson	99
18	Response to preoperative chemoradiation increases the use of sphincter‐preserving surgery in patients with locally advanced low rectal carcinoma 2003 ·Cancer ·Christopher H. Crane, John M. Skibber, Barry W. Feig, Jean‐Nicolas Vauthey, Howard D. Thames, (unknown), Miguel A. Rodrı́guez-Bigas, Robert A. Wolff, Lee M. Ellis, Marc E. Delclos, Edward H. Lin, Nora A. Janjan	153
19	Chemoradiation for adenocarcinoma of the anus 2003 ·International Journal of Radiation OncologyBiologyPhysics ·Michael A. Papagikos, Christopher H. Crane, John M. Skibber, Nora A. Janjan, Barry W. Feig, Miguel A. Rodrı́guez-Bigas, Arthur Hung, Robert A. Wolff, Marc E. Delclos, Edward H. Lin, Karen R. Cleary	45
20	Cisplatin‐based combined modality therapy for anal carcinoma 2003 ·Cancer ·Arthur Hung, Christopher H. Crane, Marc E. Delclos, Matthew T. Ballo, Jaffer A. Ajani, Edward H. Lin, Barry W. Feig, John M. Skibber, Nora A. Janjan	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact